Professor Ciclitira was an undergraduate at St Bartholomew's Hospital London, qualifying in 1971. Over the next six years his career steadily advanced though a series of positions at St Bartholomew's, Rochford Hospital, Essex, The Royal Marsden Hospital, Surrey and Addenbroke's Hospital Cambridge. In 1977 he progressed his training successfully completing an MD followed by a PhD at the MRC laboratory of Molecular Biology Cambridge. Accreditation in general medicine and gastroenterology followed in 1982. From Senior Registrar at Guy�s Hospital London he was appointed in 1983 a Consultant Physician and Gastroenterologist at both Guy�s and St Thomas� Hospitals. He was appointed Professor of Gastroenterology in 1994 where he continues to practice.
He is the Head of Department of Gastroenterology (GKT) Research Unit at St Thomas� Hospital where he specialises in malabsorption including coeliac disease, inflammatory bowel disease and peptic ulcer. Internationally renown as author of over 250 clinical and scientific publications, Professor Ciclitira lectures worldwide. Both the American (2001-2012) and British Societies of Gastroenterology (2000-2012) commissioned him to write the guidelines for treating and management of coeliac disease.
Professor Ciclitira was awarded the British Society of Gastroenterology research medal in 1982, The UK and Eire Lilly Gastroenterology Award in 1988, the European Society of Gastroenterology award in 1989 and the Norman Tanner Gastroenterology Medal by St George's Hospital Medical School in 2000. He is a fellow of The Royal College of Physicians London (FRCP) and the American Gastroenterology Association (FAGA). He was Royal College of Physicians London lecturer in medicine in 2002.
He was jointly given a research award by the Institute of Technology of the German government 2000 to develop variants of wheat, barley and rye that are non-toxic to the patients with coeliac disease but which retain the nutritional and baking qualities of the original cultivars.
He was jointly given a research award by the Institute of Technology of the German Government in 2000 to develop variants of wheat, barley and rye that are non toxic to the patients with coeliac disease but which retain the nutritional and baking qualities of the original cultivars.